CARE vs NEWTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CARE

59.8
AI Score
VS
CARE Wins

NEWTI

58.8
AI Score

Investment Advisor Scores

CARE

Aug 22, 2026
60score
Recommendation
HOLD

NEWTI

Aug 22, 2026
59score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE NEWTI Winner
Forward P/E 13.6612 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 68.3% 0.0% CARE
Earnings Growth 253.9% 0.0% CARE
Tradestie Score 59.8/100 58.8/100 CARE
Profit Margin 44.9% 0.0% CARE
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD STRONG BUY NEWTI

Relative Price Performance (Last 90 Days)

CARE 1M: -7.8% · 3M: +16.0% NEWTI 1M: +0.4% · 3M: +0.9%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 39.7 · Price: $31.25

NEWTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.8 · Price: $25.59

Fundamentals Snapshot

Metric CARE NEWTI
Market Cap
Forward P/E 12.1 0.0
Trailing P/E 5.3
Revenue (TTM)
Revenue Growth 0.7% 0.0%
Gross Margin 1.0%
Operating Margin 0.6% 0.0%
EPS 5.80 0.00
Dividend Yield 0.00% 0.08%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.